| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 2.61e-06 | 12 | 174 | 4 | GO:0016175 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 2.42e-05 | 20 | 174 | 4 | GO:0050664 | |
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 7.46e-05 | 10 | 174 | 3 | GO:0016176 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 8.80e-05 | 120 | 174 | 7 | GO:0008013 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 2.36e-04 | 35 | 174 | 4 | GO:0043325 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | WWP2 CUL9 TRIM22 MEFV MEX3C RING1 TRIM33 RNFT2 RNFT1 MARCHF1 RNF111 | 4.35e-04 | 372 | 174 | 11 | GO:0061630 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | SPRY1 DVL3 LAMA5 PTCH1 PTK7 GREB1L CELSR1 C2CD3 CSF1 TIE1 NFATC1 BSG PKHD1 DCHS1 KDM2B | 2.81e-06 | 421 | 173 | 15 | GO:0060562 |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of gram-positive bacterium | 5.73e-06 | 5 | 173 | 3 | GO:0070946 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | SPRY1 LAMA5 PTCH1 GREB1L CELSR1 CSF1 TIE1 NFATC1 PKHD1 DCHS1 | 6.93e-06 | 198 | 173 | 10 | GO:0048754 |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity | 1.68e-05 | 19 | 173 | 4 | GO:0090175 | |
| GeneOntologyBiologicalProcess | NADP catabolic process | 1.98e-05 | 7 | 173 | 3 | GO:0006742 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of fungus | 1.98e-05 | 7 | 173 | 3 | GO:0070947 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | BCL9L ABI1 FGD2 TRIO NUMBL MINK1 DVL3 LAMA5 CDH23 PDZD7 RREB1 PTCH1 ITPKA PTK7 KIAA0319 GRIP1 ATXN2 FGD4 SEMA3B PKHD1 DIXDC1 RIMS1 STRC PLEKHO1 STRCP1 | 2.19e-05 | 1194 | 173 | 25 | GO:0000902 |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 3.11e-05 | 22 | 173 | 4 | GO:0050665 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | SPRY1 LAMA5 PTCH1 GREB1L CELSR1 CSF1 TIE1 NFATC1 PKHD1 DCHS1 | 3.17e-05 | 236 | 173 | 10 | GO:0061138 |
| GeneOntologyBiologicalProcess | establishment of planar polarity | 3.26e-05 | 44 | 173 | 5 | GO:0001736 | |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 3.41e-05 | 73 | 173 | 6 | GO:0001738 | |
| GeneOntologyBiologicalProcess | establishment of tissue polarity | 3.65e-05 | 45 | 173 | 5 | GO:0007164 | |
| GeneOntologyBiologicalProcess | auditory receptor cell stereocilium organization | 6.19e-05 | 26 | 173 | 4 | GO:0060088 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | SPRY1 LAMA5 PTCH1 GREB1L CELSR1 CSF1 TIE1 NFATC1 PKHD1 DCHS1 | 6.72e-05 | 258 | 173 | 10 | GO:0001763 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | SPRY1 DVL3 LAMA5 RREB1 PTCH1 PTK7 GREB1L CELSR1 C2CD3 CSF1 TIE1 NFATC1 BSG PKHD1 DCHS1 KDM2B | 6.89e-05 | 619 | 173 | 16 | GO:0002009 |
| GeneOntologyBiologicalProcess | neural plate axis specification | 6.99e-05 | 2 | 173 | 2 | GO:0021997 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst involved in inflammatory response | 9.11e-05 | 11 | 173 | 3 | GO:0060264 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 1.10e-04 | 129 | 173 | 7 | GO:0042472 | |
| GeneOntologyBiologicalProcess | auditory receptor cell morphogenesis | 1.26e-04 | 31 | 173 | 4 | GO:0002093 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in inflammatory response | 1.56e-04 | 13 | 173 | 3 | GO:0002536 | |
| GeneOntologyBiologicalProcess | cochlea development | 1.59e-04 | 61 | 173 | 5 | GO:0090102 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.86e-04 | 187 | 173 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | branching involved in lymph vessel morphogenesis | 2.09e-04 | 3 | 173 | 2 | GO:0060854 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | 2.43e-04 | 302 | 173 | 10 | GO:0022604 | |
| GeneOntologyBiologicalProcess | regulation of establishment of planar polarity involved in neural tube closure | 2.45e-04 | 15 | 173 | 3 | GO:0090178 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 2.47e-04 | 247 | 173 | 9 | GO:0009612 | |
| GeneOntologyBiologicalProcess | inner ear development | 2.95e-04 | 253 | 173 | 9 | GO:0048839 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of bacterium | 3.00e-04 | 16 | 173 | 3 | GO:0070944 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity involved in neural tube closure | 3.00e-04 | 16 | 173 | 3 | GO:0090177 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 3.26e-04 | 154 | 173 | 7 | GO:0042471 | |
| GeneOntologyBiologicalProcess | regulation of animal organ morphogenesis | 3.33e-04 | 110 | 173 | 6 | GO:2000027 | |
| GeneOntologyBiologicalProcess | auditory receptor cell development | 3.45e-04 | 40 | 173 | 4 | GO:0060117 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SPRY1 FOXP2 DVL3 LAMA5 CDH23 PDZD7 PTCH1 PTK7 RING1 GREB1L NCOR2 CELSR1 C2CD3 CSF1 NFATC1 BSG GLI1 RECQL4 PKHD1 DCHS1 KDM2B STRC STRCP1 | 4.01e-04 | 1269 | 173 | 23 | GO:0009887 |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 4.21e-04 | 75 | 173 | 5 | GO:0050982 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity of embryonic epithelium | 4.31e-04 | 18 | 173 | 3 | GO:0042249 | |
| GeneOntologyBiologicalProcess | lamellipodium morphogenesis | 4.31e-04 | 18 | 173 | 3 | GO:0072673 | |
| GeneOntologyBiologicalProcess | response to yeast | 4.31e-04 | 18 | 173 | 3 | GO:0001878 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of symbiont cell | 5.09e-04 | 19 | 173 | 3 | GO:0070943 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ABI1 TRIO NUMBL MINK1 DVL3 LAMA5 RREB1 PTCH1 ITPKA PTK7 KIAA0319 GRIP1 ATXN2 SEMA3B DIXDC1 RIMS1 PLEKHO1 | 5.46e-04 | 819 | 173 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | epithelium development | SPRY1 ABI1 FOXP2 DVL3 LAMA5 CDH23 PDZD7 RREB1 PTCH1 PTK7 GREB1L NCOR2 CELSR1 C2CD3 CSF1 TIE1 NFATC1 BSG GLI1 PKHD1 DCHS1 KDM2B STRC STRCP1 TJP3 | 5.62e-04 | 1469 | 173 | 25 | GO:0060429 |
| GeneOntologyBiologicalProcess | reactive oxygen species biosynthetic process | 5.67e-04 | 80 | 173 | 5 | GO:1903409 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ABI1 TRIO NUMBL MINK1 LAMA5 CDH23 PDZD7 PTCH1 ITPKA PTK7 KIAA0319 GRIP1 SEMA3B DIXDC1 STRC STRCP1 | 5.78e-04 | 748 | 173 | 16 | GO:0048667 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | SPRY1 DVL3 LAMA5 RREB1 PTCH1 PTK7 GREB1L CELSR1 C2CD3 CSF1 TIE1 NFATC1 BSG PKHD1 DCHS1 KDM2B | 5.95e-04 | 750 | 173 | 16 | GO:0048729 |
| GeneOntologyBiologicalProcess | respiratory burst involved in defense response | 5.95e-04 | 20 | 173 | 3 | GO:0002679 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ABI1 TRIO NUMBL MINK1 DVL3 LAMA5 RREB1 PTCH1 ITPKA PTK7 KIAA0319 GRIP1 ATXN2 SEMA3B DIXDC1 RIMS1 PLEKHO1 | 6.01e-04 | 826 | 173 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | neutrophil mediated cytotoxicity | 6.90e-04 | 21 | 173 | 3 | GO:0070942 | |
| GeneOntologyBiologicalProcess | ear development | 6.97e-04 | 285 | 173 | 9 | GO:0043583 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 7.86e-04 | 351 | 173 | 10 | GO:0048562 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle contraction | 7.94e-04 | 22 | 173 | 3 | GO:0045986 | |
| GeneOntologyBiologicalProcess | superoxide anion generation | 8.15e-04 | 50 | 173 | 4 | GO:0042554 | |
| GeneOntologyBiologicalProcess | modification of synaptic structure | 8.78e-04 | 51 | 173 | 4 | GO:0099563 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst | 9.08e-04 | 23 | 173 | 3 | GO:0060263 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception of sound | 9.08e-04 | 23 | 173 | 3 | GO:0050910 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 1.36e-05 | 18 | 176 | 4 | GO:0043020 | |
| GeneOntologyCellularComponent | stereocilium tip | 3.16e-05 | 22 | 176 | 4 | GO:0032426 | |
| GeneOntologyCellularComponent | dendrite | CABP1 CACNA1D ZC3H14 FMR1 NCF1 MINK1 PTCH1 SHISA7 RPH3A ITPKA GRIP1 KCNJ12 PRKAA2 TANC1 IGSF9B KCNJ18 NCF1C NCF1B SHISA8 | 1.18e-04 | 858 | 176 | 19 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CABP1 CACNA1D ZC3H14 FMR1 NCF1 MINK1 PTCH1 SHISA7 RPH3A ITPKA GRIP1 KCNJ12 PRKAA2 TANC1 IGSF9B KCNJ18 NCF1C NCF1B SHISA8 | 1.22e-04 | 860 | 176 | 19 | GO:0097447 |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 1.99e-04 | 14 | 176 | 3 | GO:0097732 | |
| GeneOntologyCellularComponent | kinocilium | 1.99e-04 | 14 | 176 | 3 | GO:0060091 | |
| GeneOntologyCellularComponent | postsynaptic density | CABP1 ABI1 FMR1 MINK1 SHISA7 GRIP1 DROSHA SORCS3 TANC1 IGSF9B RIMS1 SHISA8 | 4.57e-04 | 451 | 176 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | nuclear body | SETD1A ZC3H14 FMR1 TCF20 HDAC4 BMP2K ZC3H13 HIF3A RREB1 TRIM22 RING1 NCOR2 CSF1 NFATC1 PRKAA2 REXO1L1P RNF111 AGAP3 | 6.32e-04 | 903 | 176 | 18 | GO:0016604 |
| GeneOntologyCellularComponent | asymmetric synapse | CABP1 ABI1 FMR1 MINK1 SHISA7 GRIP1 DROSHA SORCS3 TANC1 IGSF9B RIMS1 SHISA8 | 7.47e-04 | 477 | 176 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 1.03e-03 | 6 | 176 | 2 | GO:0098683 | |
| GeneOntologyCellularComponent | cell leading edge | CACNA1D ABI1 FGD2 PIEZO1 APC2 SHISA7 MEFV DUOX1 FGD4 APPL1 PLEKHO1 SHISA8 | 1.12e-03 | 500 | 176 | 12 | GO:0031252 |
| GeneOntologyCellularComponent | postsynaptic specialization | CABP1 ABI1 FMR1 MINK1 SHISA7 GRIP1 DROSHA SORCS3 TANC1 IGSF9B RIMS1 SHISA8 | 1.18e-03 | 503 | 176 | 12 | GO:0099572 |
| GeneOntologyCellularComponent | glutamatergic synapse | CABP1 ABI1 FMR1 TRIO NUMBL DVL3 LAMA5 SHISA7 ITPKA GRIP1 DROSHA SORCS3 APPL1 DIXDC1 TANC1 RIMS1 | 1.52e-03 | 817 | 176 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | somatodendritic compartment | CABP1 CACNA1D ZC3H14 FMR1 NCF1 MINK1 PTCH1 SHISA7 RPH3A ITPKA PTK7 GRIP1 KCNJ12 PRKAA2 DIXDC1 TANC1 IGSF9B KCNJ18 NCF1C NCF1B SHISA8 | 1.59e-03 | 1228 | 176 | 21 | GO:0036477 |
| GeneOntologyCellularComponent | neuron to neuron synapse | CABP1 ABI1 FMR1 MINK1 SHISA7 GRIP1 DROSHA SORCS3 TANC1 IGSF9B RIMS1 SHISA8 | 1.64e-03 | 523 | 176 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | leading edge membrane | 2.06e-03 | 210 | 176 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | postsynapse | CABP1 ABI1 FMR1 TRIO MINK1 APC2 SHISA7 RPH3A ITPKA GRIP1 DROSHA SORCS3 APPL1 DIXDC1 TANC1 IGSF9B RIMS1 SHISA8 | 2.41e-03 | 1018 | 176 | 18 | GO:0098794 |
| GeneOntologyCellularComponent | catenin complex | 2.43e-03 | 32 | 176 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | dendritic spine neck | 2.44e-03 | 9 | 176 | 2 | GO:0044326 | |
| MousePheno | abnormal outer hair cell kinocilium location or orientation | 9.61e-08 | 6 | 127 | 4 | MP:0030961 | |
| MousePheno | abnormal cochlear hair cell stereociliary bundle morphology | 1.33e-07 | 91 | 127 | 9 | MP:0004521 | |
| MousePheno | abnormal outer hair cell kinocilium morphology | 1.31e-06 | 10 | 127 | 4 | MP:0011062 | |
| MousePheno | abnormal outer hair cell stereociliary bundle morphology | 2.65e-06 | 68 | 127 | 7 | MP:0004527 | |
| MousePheno | abnormal cochlear outer hair cell physiology | 4.75e-06 | 28 | 127 | 5 | MP:0004434 | |
| MousePheno | abnormal angiotensin I-converting enzyme activity | 1.44e-05 | 6 | 127 | 3 | MP:0013254 | |
| MousePheno | increased angiotensin I-converting enzyme activity | 1.44e-05 | 6 | 127 | 3 | MP:0003184 | |
| MousePheno | abnormal orientation of cochlear hair cell stereociliary bundles | 1.49e-05 | 35 | 127 | 5 | MP:0004522 | |
| MousePheno | liver abscess | 2.50e-05 | 7 | 127 | 3 | MP:0003332 | |
| MousePheno | abnormal cochlear hair cell physiology | 2.92e-05 | 40 | 127 | 5 | MP:0004432 | |
| MousePheno | abnormal kinocilium morphology | 3.45e-05 | 21 | 127 | 4 | MP:0011060 | |
| MousePheno | abnormal nonmotile primary cilium morphology | 4.07e-05 | 70 | 127 | 6 | MP:0013205 | |
| MousePheno | increased heart atrium size | 5.82e-05 | 46 | 127 | 5 | MP:0008725 | |
| MousePheno | abnormal hair cell physiology | 7.92e-05 | 49 | 127 | 5 | MP:0003879 | |
| MousePheno | abnormal primary cilium morphology | 7.96e-05 | 114 | 127 | 7 | MP:0013203 | |
| MousePheno | impaired granulocyte bactericidal activity | 8.39e-05 | 10 | 127 | 3 | MP:0005074 | |
| MousePheno | abnormal cochlear hair cell morphology | 9.37e-05 | 202 | 127 | 9 | MP:0002622 | |
| MousePheno | abnormal cochlear sensory epithelium morphology | 1.13e-04 | 207 | 127 | 9 | MP:0003308 | |
| MousePheno | abnormal organ of Corti morphology | 1.21e-04 | 209 | 127 | 9 | MP:0000042 | |
| MousePheno | abnormal heart atrium size | 1.27e-04 | 54 | 127 | 5 | MP:0031576 | |
| MousePheno | abnormal hair cell morphology | 1.45e-04 | 214 | 127 | 9 | MP:0000045 | |
| MousePheno | increased cell chemotaxis | 2.44e-04 | 3 | 127 | 2 | MP:0011824 | |
| MousePheno | abnormal mechanoreceptor morphology | 2.57e-04 | 231 | 127 | 9 | MP:0000972 | |
| MousePheno | abnormal cochlear labyrinth morphology | 2.92e-04 | 235 | 127 | 9 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 2.92e-04 | 235 | 127 | 9 | MP:0003169 | |
| MousePheno | enhanced long-term potentiation | 4.04e-04 | 69 | 127 | 5 | MP:0003008 | |
| MousePheno | abnormal cochlea morphology | 4.33e-04 | 248 | 127 | 9 | MP:0000031 | |
| MousePheno | craniorachischisis | 4.54e-04 | 17 | 127 | 3 | MP:0008784 | |
| MousePheno | abnormal sensory neuron physiology | 4.92e-04 | 72 | 127 | 5 | MP:0010055 | |
| MousePheno | absent distortion product otoacoustic emissions | 5.07e-04 | 41 | 127 | 4 | MP:0004737 | |
| MousePheno | abnormal cochlear microphonics | 5.41e-04 | 18 | 127 | 3 | MP:0004412 | |
| MousePheno | decreased susceptibility to Orthomyxoviridae infection | 5.41e-04 | 18 | 127 | 3 | MP:0020947 | |
| MousePheno | abnormal cochlear outer hair cell morphology | 6.16e-04 | 159 | 127 | 7 | MP:0004399 | |
| MousePheno | abnormal cochlear potential | 6.38e-04 | 19 | 127 | 3 | MP:0006332 | |
| MousePheno | abnormal membranous labyrinth morphology | 6.44e-04 | 262 | 127 | 9 | MP:0000035 | |
| MousePheno | abnormal branching involved in ureteric bud morphogenesis | 7.26e-04 | 45 | 127 | 4 | MP:0010981 | |
| Domain | Znf_FYVE-rel | 1.25e-05 | 34 | 168 | 5 | IPR017455 | |
| Domain | Znf_FYVE | 2.19e-05 | 38 | 168 | 5 | IPR000306 | |
| Domain | ZF_FYVE | 2.83e-05 | 40 | 168 | 5 | PS50178 | |
| Domain | PH | IRS4 FGD2 TRIO PLEKHF1 PLEKHG2 NIBAN3 FGD4 ARHGEF39 APPL1 PLEKHO1 AGAP3 | 4.47e-05 | 278 | 168 | 11 | SM00233 |
| Domain | PH_domain | IRS4 FGD2 TRIO PLEKHF1 PLEKHG2 NIBAN3 FGD4 ARHGEF39 APPL1 PLEKHO1 AGAP3 | 4.77e-05 | 280 | 168 | 11 | IPR001849 |
| Domain | Znf_FYVE_PHD | 5.60e-05 | 147 | 168 | 8 | IPR011011 | |
| Domain | - | FGD2 PLEKHF1 TRIM22 RPH3A MEX3C RING1 TRIM33 RNFT2 FGD4 RNFT1 KDM2B RIMS1 MARCHF1 RNF111 | 5.69e-05 | 449 | 168 | 14 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | FGD2 PLEKHF1 TRIM22 RPH3A MEX3C RING1 TRIM33 RNFT2 FGD4 RNFT1 KDM2B RIMS1 MARCHF1 RNF111 | 7.19e-05 | 459 | 168 | 14 | IPR013083 |
| Domain | K_chnl_inward-rec_Kir2.2 | 8.04e-05 | 2 | 168 | 2 | IPR003272 | |
| Domain | Cadherin | 9.59e-05 | 118 | 168 | 7 | IPR002126 | |
| Domain | PKD | 1.12e-04 | 11 | 168 | 3 | PS50093 | |
| Domain | PKD_dom | 1.12e-04 | 11 | 168 | 3 | IPR000601 | |
| Domain | - | 1.12e-04 | 11 | 168 | 3 | 2.60.40.670 | |
| Domain | PH_DOMAIN | IRS4 FGD2 TRIO PLEKHF1 PLEKHG2 FGD4 ARHGEF39 APPL1 PLEKHO1 AGAP3 | 2.23e-04 | 279 | 168 | 10 | PS50003 |
| Domain | - | IRS4 FGD2 TRIO NUMBL PLEKHF1 PLEKHG2 NIBAN3 FGD4 ARHGEF39 APPL1 PLEKHO1 AGAP3 | 2.25e-04 | 391 | 168 | 12 | 2.30.29.30 |
| Domain | K_chnl_inward-rec_Kir_N | 2.40e-04 | 3 | 168 | 2 | IPR013673 | |
| Domain | IRK_N | 2.40e-04 | 3 | 168 | 2 | PF08466 | |
| Domain | PDZ | 2.89e-04 | 141 | 168 | 7 | PF00595 | |
| Domain | RhoGEF | 3.66e-04 | 68 | 168 | 5 | SM00325 | |
| Domain | PDZ | 3.88e-04 | 148 | 168 | 7 | SM00228 | |
| Domain | RhoGEF | 4.19e-04 | 70 | 168 | 5 | PF00621 | |
| Domain | DH_2 | 4.19e-04 | 70 | 168 | 5 | PS50010 | |
| Domain | - | 4.21e-04 | 150 | 168 | 7 | 2.30.42.10 | |
| Domain | PDZ | 4.38e-04 | 151 | 168 | 7 | PS50106 | |
| Domain | - | 4.47e-04 | 71 | 168 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 4.47e-04 | 71 | 168 | 5 | IPR000219 | |
| Domain | PDZ | 4.56e-04 | 152 | 168 | 7 | IPR001478 | |
| Domain | Cadherin_CS | 4.57e-04 | 109 | 168 | 6 | IPR020894 | |
| Domain | Pecanex_C | 4.77e-04 | 4 | 168 | 2 | PF05041 | |
| Domain | Dsh/Dvl-rel | 4.77e-04 | 4 | 168 | 2 | IPR015506 | |
| Domain | Pecanex | 4.77e-04 | 4 | 168 | 2 | IPR007735 | |
| Domain | PH_dom-like | IRS4 FGD2 TRIO NUMBL PLEKHF1 PLEKHG2 NIBAN3 FGD4 ARHGEF39 APPL1 PLEKHO1 AGAP3 | 4.88e-04 | 426 | 168 | 12 | IPR011993 |
| Domain | CADHERIN_1 | 5.53e-04 | 113 | 168 | 6 | PS00232 | |
| Domain | Cadherin | 5.53e-04 | 113 | 168 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 5.80e-04 | 114 | 168 | 6 | PS50268 | |
| Domain | - | 5.80e-04 | 114 | 168 | 6 | 2.60.40.60 | |
| Domain | CA | 6.07e-04 | 115 | 168 | 6 | SM00112 | |
| Domain | Cadherin-like | 6.36e-04 | 116 | 168 | 6 | IPR015919 | |
| Domain | MANEC | 7.90e-04 | 5 | 168 | 2 | SM00765 | |
| Domain | MANSC_N | 7.90e-04 | 5 | 168 | 2 | IPR011106 | |
| Domain | Znf_C3HC4_RING-type | 9.49e-04 | 172 | 168 | 7 | IPR018957 | |
| Domain | GUANYLATE_KINASE_2 | 1.11e-03 | 23 | 168 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 1.11e-03 | 23 | 168 | 3 | PS00856 | |
| Domain | PH | 1.12e-03 | 229 | 168 | 8 | PF00169 | |
| Domain | MANSC | 1.18e-03 | 6 | 168 | 2 | PS50986 | |
| Domain | MANSC_dom | 1.18e-03 | 6 | 168 | 2 | IPR013980 | |
| Domain | Guanylate_kin | 1.60e-03 | 26 | 168 | 3 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 1.60e-03 | 26 | 168 | 3 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 1.60e-03 | 26 | 168 | 3 | IPR008144 | |
| Domain | GuKc | 1.60e-03 | 26 | 168 | 3 | SM00072 | |
| Domain | DIX | 1.64e-03 | 7 | 168 | 2 | PF00778 | |
| Domain | DIX | 1.64e-03 | 7 | 168 | 2 | IPR001158 | |
| Domain | DIX | 1.64e-03 | 7 | 168 | 2 | PS50841 | |
| Domain | DAX | 1.64e-03 | 7 | 168 | 2 | SM00021 | |
| Domain | FYVE | 2.20e-03 | 29 | 168 | 3 | PF01363 | |
| Domain | FYVE | 2.20e-03 | 29 | 168 | 3 | SM00064 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ABI1 FGD2 TRIO WWP2 NCF1 PLEKHG2 ANKLE2 ARHGAP6 FGD4 ARHGEF39 SRGAP1 NCF1C NCF1B GOLGA3 | 1.20e-05 | 439 | 114 | 14 | MM15595 |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 4.18e-05 | 9 | 114 | 3 | MM14524 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 6.08e-05 | 52 | 114 | 5 | MM14743 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 7.26e-05 | 87 | 114 | 6 | MM15600 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 8.64e-05 | 175 | 114 | 8 | MM15599 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 1.05e-04 | 93 | 114 | 6 | MM15609 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.12e-04 | 59 | 114 | 5 | M11215 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 1.21e-04 | 60 | 114 | 5 | M40048 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 1.56e-04 | 34 | 114 | 4 | MM1399 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ABI1 FGD2 TRIO WWP2 NCF1 DVL3 PLEKHG2 ANKLE2 ARHGAP6 FGD4 ARHGEF39 SRGAP1 NCF1C NCF1B GOLGA3 | 2.27e-04 | 649 | 114 | 15 | MM15690 |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 2.52e-04 | 70 | 114 | 5 | MM14824 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ABI1 FGD2 TRIO WWP2 NCF1 PLEKHG2 ANKLE2 ARHGAP6 FGD4 ARHGEF39 SRGAP1 GOLGA3 | 2.80e-04 | 450 | 114 | 12 | M27078 |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 3.70e-04 | 76 | 114 | 5 | M19832 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 3.94e-04 | 77 | 114 | 5 | MM15044 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 4.70e-04 | 80 | 114 | 5 | M800 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 6.21e-04 | 85 | 114 | 5 | MM14746 | |
| Pubmed | MAGI1 ABI1 FMR1 TCF20 HDAC4 FOXP2 TRIO NUMBL MINK1 APC2 ZNFX1 JAKMIP3 SHISA7 RPH3A KIAA0319 NCOR2 STOX2 CNTNAP5 ATXN2 ZC3H4 DCHS1 APPL1 DIXDC1 RIMS1 GOLGA3 | 6.31e-11 | 963 | 184 | 25 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAGI1 ABI1 IRS4 TCF20 HDAC4 TRIO NUMBL WWP2 MINK1 MAGI3 PLEKHG2 ARAF MEX3C GRIP1 STOX2 C2CD3 CSNK1D SRGAP1 PRKAA2 TANC1 USP6NL AGAP3 | 1.30e-09 | 861 | 184 | 22 | 36931259 |
| Pubmed | 2.62e-08 | 7 | 184 | 4 | 9494100 | ||
| Pubmed | Cloning and functional expression of the mouse homologue of p47phox. | 2.62e-08 | 7 | 184 | 4 | 8119734 | |
| Pubmed | 9.36e-08 | 9 | 184 | 4 | 10433265 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A FAM89A PCNX3 TRIO SPEG PIEZO1 LAMA5 CUL9 PTCH1 MBD6 WASHC2A NCOR2 CELSR1 C2CD3 SCAP NFATC1 GLI1 PCNX1 TANC1 SLC45A1 AGAP3 TJP3 | 1.10e-07 | 1105 | 184 | 22 | 35748872 |
| Pubmed | 1.22e-07 | 23 | 184 | 5 | 9225980 | ||
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 1.46e-07 | 3 | 184 | 3 | 27044504 | |
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 1.46e-07 | 3 | 184 | 3 | 18787174 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 24873968 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 22184329 | ||
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 1.46e-07 | 3 | 184 | 3 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 1.46e-07 | 3 | 184 | 3 | 20142487 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 1.46e-07 | 3 | 184 | 3 | 25565313 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 39357591 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 11435342 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 31118934 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 16041040 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 1.46e-07 | 3 | 184 | 3 | 18703411 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 17307863 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 1.46e-07 | 3 | 184 | 3 | 27829407 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 22376231 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 1.46e-07 | 3 | 184 | 3 | 28274989 | |
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 1.46e-07 | 3 | 184 | 3 | 12364355 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 34557202 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 28467721 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 10670582 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 26528554 | ||
| Pubmed | The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. | 1.46e-07 | 3 | 184 | 3 | 19052348 | |
| Pubmed | Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. | 1.46e-07 | 3 | 184 | 3 | 20864666 | |
| Pubmed | Reactive oxygen species delay control of lymphocytic choriomeningitis virus. | 1.46e-07 | 3 | 184 | 3 | 23328631 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 34572995 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 17114280 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 25989352 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 17404617 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 17332431 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 36592568 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 30504842 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 33705493 | ||
| Pubmed | Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. | 1.46e-07 | 3 | 184 | 3 | 23965970 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 15513930 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 15033459 | ||
| Pubmed | Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles. | 1.46e-07 | 3 | 184 | 3 | 20828610 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 20817944 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 36853827 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 23024271 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 21253614 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 15310853 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 31393787 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 10725280 | ||
| Pubmed | Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice. | 1.46e-07 | 3 | 184 | 3 | 34970267 | |
| Pubmed | Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility. | 1.46e-07 | 3 | 184 | 3 | 25689796 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 14993144 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 22050439 | ||
| Pubmed | The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. | 1.46e-07 | 3 | 184 | 3 | 12031896 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 11249873 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 15936744 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 25628043 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 12560337 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 35276443 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 19381132 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 12176908 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 9329953 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 10799876 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 11834706 | ||
| Pubmed | A model of chronic enthesitis and new bone formation characterized by multimodal imaging. | 1.46e-07 | 3 | 184 | 3 | 30045841 | |
| Pubmed | Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease. | 1.46e-07 | 3 | 184 | 3 | 19635825 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 35788118 | ||
| Pubmed | Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation. | 1.46e-07 | 3 | 184 | 3 | 17310103 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 18036262 | ||
| Pubmed | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. | 1.46e-07 | 3 | 184 | 3 | 10678931 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 17167081 | ||
| Pubmed | Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. | 1.46e-07 | 3 | 184 | 3 | 24358335 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 10891396 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 25474113 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 26209274 | ||
| Pubmed | NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. | 1.46e-07 | 3 | 184 | 3 | 11018074 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 9116268 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 20686129 | ||
| Pubmed | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. | 1.46e-07 | 3 | 184 | 3 | 21570954 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 12958309 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 23482812 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 10085000 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 10987289 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 21435178 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 29228045 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 22155727 | ||
| Pubmed | Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. | 1.46e-07 | 3 | 184 | 3 | 24576409 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 26645958 | ||
| Pubmed | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. | 1.46e-07 | 3 | 184 | 3 | 24549323 | |
| Pubmed | NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. | 1.46e-07 | 3 | 184 | 3 | 20881184 | |
| Pubmed | Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. | 1.46e-07 | 3 | 184 | 3 | 19168575 | |
| Pubmed | NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. | 1.46e-07 | 3 | 184 | 3 | 19503084 | |
| Pubmed | Genetic requirement of p47phox for superoxide production by murine microglia. | 1.46e-07 | 3 | 184 | 3 | 11156938 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 10772875 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 27798190 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 20702812 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 26455429 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 15626477 | ||
| Interaction | YWHAH interactions | MAGI1 ZC3H14 ABI1 IRS4 TCF20 HDAC4 TRIO NUMBL SPEG ZC3H13 MINK1 MAGI3 MCM2 PLEKHG2 RPH3A ARAF MEX3C GRIP1 STOX2 C2CD3 CSNK1D SRGAP1 RECQL4 PRKAA2 APPL1 TANC1 RIMS1 USP6NL AGAP3 | 1.10e-07 | 1102 | 177 | 29 | int:YWHAH |
| Interaction | CACNA1C interactions | 1.05e-06 | 61 | 177 | 7 | int:CACNA1C | |
| Interaction | EGR2 interactions | 2.09e-05 | 171 | 177 | 9 | int:EGR2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 5.03e-05 | 415 | 184 | 9 | chr12q24 | |
| Cytoband | 15q15.3 | 1.37e-04 | 25 | 184 | 3 | 15q15.3 | |
| Cytoband | 22q13.3 | 2.37e-04 | 6 | 184 | 2 | 22q13.3 | |
| Cytoband | 7q11.23 | 6.47e-04 | 97 | 184 | 4 | 7q11.23 | |
| Cytoband | 12q24.33 | 9.59e-04 | 48 | 184 | 3 | 12q24.33 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 4.58e-07 | 25 | 115 | 5 | 775 | |
| GeneFamily | PDZ domain containing | 5.30e-05 | 152 | 115 | 7 | 1220 | |
| GeneFamily | Dishevelled segment polarity proteins|PDZ domain containing | 2.39e-04 | 4 | 115 | 2 | 505 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.49e-04 | 206 | 115 | 7 | 682 | |
| GeneFamily | Ring finger proteins | 3.76e-04 | 275 | 115 | 8 | 58 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.75e-04 | 161 | 115 | 6 | 593 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 5.86e-04 | 26 | 115 | 3 | 904 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.26e-04 | 66 | 115 | 4 | 722 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 9.90e-04 | 31 | 115 | 3 | 81 | |
| GeneFamily | Shisa family members | 1.10e-03 | 8 | 115 | 2 | 742 | |
| GeneFamily | Zinc fingers CCCH-type | 1.41e-03 | 35 | 115 | 3 | 73 | |
| GeneFamily | Immunoglobulin like domain containing | 1.47e-03 | 193 | 115 | 6 | 594 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 4.54e-03 | 16 | 115 | 2 | 276 | |
| GeneFamily | Cadherin related | 5.12e-03 | 17 | 115 | 2 | 24 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 5.12e-03 | 17 | 115 | 2 | 1291 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 7.77e-08 | 185 | 183 | 9 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.07e-07 | 192 | 183 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-07 | 198 | 183 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-07 | 200 | 183 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-07 | 170 | 183 | 8 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.76e-07 | 184 | 183 | 8 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-06 | 185 | 183 | 8 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-06 | 188 | 183 | 8 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.15e-06 | 188 | 183 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-06 | 192 | 183 | 8 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 193 | 183 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-06 | 193 | 183 | 8 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-06 | 194 | 183 | 8 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-06 | 194 | 183 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-06 | 197 | 183 | 8 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 199 | 183 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.75e-06 | 199 | 183 | 8 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-06 | 199 | 183 | 8 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 199 | 183 | 8 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 199 | 183 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-06 | 199 | 183 | 8 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.82e-06 | 200 | 183 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.92e-06 | 162 | 183 | 7 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.50e-06 | 169 | 183 | 7 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.50e-06 | 169 | 183 | 7 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-06 | 172 | 183 | 7 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.29e-06 | 172 | 183 | 7 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.79e-06 | 177 | 183 | 7 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-06 | 178 | 183 | 7 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 9.45e-06 | 179 | 183 | 7 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.45e-06 | 179 | 183 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 185 | 183 | 7 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 185 | 183 | 7 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-Naive_B_cells|GI_large-bowel / Manually curated celltypes from each tissue | 1.17e-05 | 185 | 183 | 7 | 1c99373c123b5e0de40b47d9d885974a747b9839 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-05 | 186 | 183 | 7 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 186 | 183 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 186 | 183 | 7 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 187 | 183 | 7 | 8e8f1f2a78ac5f13a414fd448af7d7ff1ea86f0f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-05 | 187 | 183 | 7 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.26e-05 | 187 | 183 | 7 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.26e-05 | 187 | 183 | 7 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 188 | 183 | 7 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.30e-05 | 188 | 183 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.39e-05 | 190 | 183 | 7 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 190 | 183 | 7 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 191 | 183 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.44e-05 | 191 | 183 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.44e-05 | 191 | 183 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-05 | 191 | 183 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.49e-05 | 192 | 183 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 192 | 183 | 7 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.49e-05 | 192 | 183 | 7 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 193 | 183 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-05 | 193 | 183 | 7 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-05 | 193 | 183 | 7 | 6e6c5ae39ea880ba809019a7d39f50e4e02007ed | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-05 | 193 | 183 | 7 | c04ac5884be4245b75d211046f04d76ae0cfb998 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-05 | 193 | 183 | 7 | 749faa5c592ee354733f5a7363a4277ef3462b93 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.59e-05 | 194 | 183 | 7 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 194 | 183 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 194 | 183 | 7 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 194 | 183 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.59e-05 | 194 | 183 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 194 | 183 | 7 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 194 | 183 | 7 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 194 | 183 | 7 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 194 | 183 | 7 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 194 | 183 | 7 | badefcec2af86cbcd97305f4843e84db0f3ebc66 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.59e-05 | 194 | 183 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 194 | 183 | 7 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 194 | 183 | 7 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 195 | 183 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-05 | 196 | 183 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 196 | 183 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-05 | 196 | 183 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-05 | 199 | 183 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-05 | 199 | 183 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.88e-05 | 199 | 183 | 7 | fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-05 | 199 | 183 | 7 | 8bc07beace200ae2ad41e932b72fdcc7ff08b812 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.88e-05 | 199 | 183 | 7 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-B-B_naive|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.94e-05 | 200 | 183 | 7 | 4d16545608aa4289a5e406512100c617ccee6a97 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.94e-05 | 200 | 183 | 7 | 99eb02f974ddc8d1882f4a5b34d4503d6ec0a5f5 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 183 | 7 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 183 | 7 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 136 | 183 | 6 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.57e-05 | 156 | 183 | 6 | f5889a6899904dfb7f596600b3a76857cf9d5378 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.08e-05 | 159 | 183 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 5.64e-05 | 162 | 183 | 6 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 5.84e-05 | 163 | 183 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Adult-Immune-B_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.84e-05 | 163 | 183 | 6 | 4f5821299b265663c7d0352b28285f56e1988841 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.84e-05 | 163 | 183 | 6 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-05 | 165 | 183 | 6 | 7039bb5a7af4684fbd1192230864e5cd6936e83c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-B_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-05 | 165 | 183 | 6 | d2c79653710b139794170f3d72f11392fc548ac7 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.46e-05 | 166 | 183 | 6 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.68e-05 | 167 | 183 | 6 | a54b8e03987a7b067173121902e1811a3d003692 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-05 | 169 | 183 | 6 | 87116c33c5ca8cb1862e103e5607b1df4d264569 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 1.93e-06 | 5 | 172 | 3 | DOID:3265 (implicated_via_orthology) | |
| Disease | hereditary lymphedema (is_implicated_in) | 6.70e-06 | 7 | 172 | 3 | DOID:0050580 (is_implicated_in) | |
| Disease | smoking status measurement | CABP1 CACNA1D NRAP TCF20 FOXP2 WWP2 ZNF407 PDZD7 RPH3A CSF1 ATXN2 ZC3H4 PKHD1 C12orf42 SORCS3 DIXDC1 IGSF9B RIMS1 TMEM200C GOLGA3 | 1.53e-05 | 1160 | 172 | 20 | EFO_0006527 |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 3.38e-05 | 2 | 172 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | spina bifida (is_marker_for) | 3.38e-05 | 2 | 172 | 2 | DOID:0080016 (is_marker_for) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 4.12e-05 | 12 | 172 | 3 | DOID:7148 (implicated_via_orthology) | |
| Disease | nevoid basal cell carcinoma syndrome (is_marker_for) | 1.01e-04 | 3 | 172 | 2 | DOID:2512 (is_marker_for) | |
| Disease | X-linked Aarskog syndrome (implicated_via_orthology) | 2.01e-04 | 4 | 172 | 2 | DOID:6683 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease type 4H (implicated_via_orthology) | 2.01e-04 | 4 | 172 | 2 | DOID:0110192 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease | THSD4 CACNA1D SETD1A HDAC4 SPEG PIEZO1 LINC02693 TSEN54 VARS2 RREB1 PTCH1 ARMC2 KCNJ18 | 2.11e-04 | 688 | 172 | 13 | EFO_0000341 |
| Disease | pulmonary function measurement, FEV/FEC ratio | 2.61e-04 | 53 | 172 | 4 | EFO_0003892, EFO_0004713 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | CABP1 CACNA1D ABI1 NRAP TCF20 FOXP2 MINK1 CDH23 ZNF407 CNTNAP5 ATXN2 SORCS3 IGSF9B GOLGA3 | 2.68e-04 | 801 | 172 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | progranulin measurement | 2.76e-04 | 22 | 172 | 3 | EFO_0004625 | |
| Disease | Intellectual Disability | SETD1A ZC3H14 FMR1 TCF20 HDAC4 TRIO APC2 TSEN54 PCDH12 POLR3B | 3.12e-04 | 447 | 172 | 10 | C3714756 |
| Disease | unipolar depression, depressive symptom measurement | 4.58e-04 | 26 | 172 | 3 | EFO_0003761, EFO_0007006 | |
| Disease | longevity, healthspan, parental longevity | 6.36e-04 | 29 | 172 | 3 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | forced expiratory volume | THSD4 CACNA1D SETD1A HDAC4 BMP2K WWP2 PIEZO1 TSEN54 PTCH1 ARMC2 NCOR2 DROSHA LOXL1 | 7.68e-04 | 789 | 172 | 13 | EFO_0004314 |
| Disease | central nervous system cancer | 7.76e-04 | 31 | 172 | 3 | EFO_0000326 | |
| Disease | Manic Disorder | 7.99e-04 | 71 | 172 | 4 | C0024713 | |
| Disease | waist-hip ratio | THSD4 RBL2 WWP2 CUL9 ZNF407 RREB1 C8orf34 MEFV PTK7 TRIM33 ATXN2 LOXL1 KCNJ12 SEMA3B PCNX1 DIXDC1 RIMS1 | 8.61e-04 | 1226 | 172 | 17 | EFO_0004343 |
| Disease | cortical surface area measurement | THSD4 MAGI1 SPRY1 ABI1 FOXP2 PCNX3 ZC3H13 CUL9 RREB1 PTCH1 MBD6 GRIP1 CELSR1 ATXN2 PKHD1 LINC02694 SLC38A6 AGAP3 | 9.09e-04 | 1345 | 172 | 18 | EFO_0010736 |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 9.24e-04 | 8 | 172 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | joint hypermobility measurement | 9.34e-04 | 33 | 172 | 3 | EFO_0007905 | |
| Disease | Tinnitus | 1.01e-03 | 130 | 172 | 5 | HP_0000360 | |
| Disease | triacylglycerol 58:10 measurement | 1.02e-03 | 34 | 172 | 3 | EFO_0010437 | |
| Disease | Manic | 1.14e-03 | 78 | 172 | 4 | C0338831 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.18e-03 | 9 | 172 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Depression, Bipolar | 1.19e-03 | 79 | 172 | 4 | C0005587 | |
| Disease | interleukin 4 measurement | 1.21e-03 | 36 | 172 | 3 | EFO_0008184 | |
| Disease | Vertigo | 1.36e-03 | 139 | 172 | 5 | HP_0002321 | |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 1.78e-03 | 88 | 172 | 4 | EFO_0000341, EFO_0006527 | |
| Disease | diastolic blood pressure, systolic blood pressure | CACNA1D HDAC4 SPEG ITPKA PTK7 TRIM33 C2CD3 CSF1 ATXN2 LOXL1 ACCSL | 2.00e-03 | 670 | 172 | 11 | EFO_0006335, EFO_0006336 |
| Disease | spleen volume | 2.02e-03 | 43 | 172 | 3 | EFO_0600047 | |
| Disease | chronic musculoskeletal pain | 2.15e-03 | 12 | 172 | 2 | EFO_0022195 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.15e-03 | 12 | 172 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 2.15e-03 | 12 | 172 | 2 | EFO_0008141 | |
| Disease | Neurodevelopmental Disorders | 2.17e-03 | 93 | 172 | 4 | C1535926 | |
| Disease | Gastric Adenocarcinoma | 2.31e-03 | 45 | 172 | 3 | C0278701 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.53e-03 | 13 | 172 | 2 | C1846647 | |
| Disease | aspartate aminotransferase measurement | MAGI1 TNFSF10 INHBC PIEZO1 BUD13 CPN1 PTCH1 C8orf34 NCOR2 CSF1 ATXN2 GLI1 TJP3 | 2.56e-03 | 904 | 172 | 13 | EFO_0004736 |
| Disease | alkaline phosphatase measurement | CA11 ELP5 NUMBL INHBC RBL2 WWP2 MINK1 RREB1 PTCH1 RPH3A KIAA0319 NFATC1 ATXN2 RECQL4 | 2.58e-03 | 1015 | 172 | 14 | EFO_0004533 |
| Disease | Gastrointestinal Stromal Sarcoma | 2.61e-03 | 47 | 172 | 3 | C3179349 | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 2.61e-03 | 47 | 172 | 3 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | beta-2-microglobulin measurement | 2.94e-03 | 14 | 172 | 2 | EFO_0020180 | |
| Disease | cerebral atherosclerosis | 2.94e-03 | 14 | 172 | 2 | EFO_1000860 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.95e-03 | 49 | 172 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | colorectal cancer | THSD4 BCL9L LAMA5 RREB1 C8orf34 KIAA0319 ATXN2 SRGAP1 PCNX1 TANC1 | 2.98e-03 | 604 | 172 | 10 | MONDO_0005575 |
| Disease | Gastrointestinal Stromal Tumors | 3.12e-03 | 50 | 172 | 3 | C0238198 | |
| Disease | response to peritoneal dialysis, peritoneal solute transfer rate | 3.37e-03 | 15 | 172 | 2 | EFO_0600089, EFO_0600090 | |
| Disease | trauma exposure measurement | 3.44e-03 | 172 | 172 | 5 | EFO_0010703 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 3.62e-03 | 335 | 172 | 7 | EFO_0009931 | |
| Disease | cholesteryl ester 16:1 measurement | 3.84e-03 | 16 | 172 | 2 | EFO_0010342 | |
| Disease | autism spectrum disorder (is_implicated_in) | 3.84e-03 | 16 | 172 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | smoking behavior | 3.99e-03 | 341 | 172 | 7 | EFO_0004318 | |
| Disease | coronary artery disease, factor VII measurement | 4.11e-03 | 111 | 172 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | coronary artery disease | PCNX3 INHBC MAGI3 BUD13 C8orf34 RPH3A ITPKA PTK7 KIAA0319 FNDC1 ATXN2 LOXL1 PKHD1 MARCHF1 PSRC1 | 4.38e-03 | 1194 | 172 | 15 | EFO_0001645 |
| Disease | cognitive function measurement | MAGI1 CACNA1D TCF20 INHBC RBL2 PIEZO1 PTCH1 C8orf34 STOX2 CNTNAP5 FGD4 SRGAP1 PKHD1 SORCS3 IGSF9B MARCHF1 TMEM200C | 4.41e-03 | 1434 | 172 | 17 | EFO_0008354 |
| Disease | grip strength measurement | 4.59e-03 | 350 | 172 | 7 | EFO_0006941 | |
| Disease | neutrophil-to-lymphocyte ratio | 4.68e-03 | 185 | 172 | 5 | EFO_0008447 | |
| Disease | cocaine dependence | 4.75e-03 | 58 | 172 | 3 | EFO_0002610 | |
| Disease | C-X-C motif chemokine 16 measurement | 4.86e-03 | 18 | 172 | 2 | EFO_0010911 | |
| Disease | cognitive function measurement, self reported educational attainment | 4.96e-03 | 355 | 172 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | lymphocyte count | CA11 WWP2 PIEZO1 MINK1 CDH23 HIF3A VARS2 RREB1 ANKLE2 NIBAN3 RPH3A CSF1 NFATC1 ATXN2 PRKAA2 LINC02694 GOLGA3 | 5.40e-03 | 1464 | 172 | 17 | EFO_0004587 |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 5.41e-03 | 19 | 172 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 5.72e-03 | 62 | 172 | 3 | EFO_0803360, EFO_0803362 | |
| Disease | cortical thickness | THSD4 MAGI1 FOXP2 CUL9 RREB1 PTCH1 MBD6 GRIP1 DUOX1 CELSR1 ATXN2 LRP11 PKHD1 AGAP3 | 5.79e-03 | 1113 | 172 | 14 | EFO_0004840 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSGQRRGRVPRDHSI | 11 | Q4AC99 | |
| HSPSQRSHRGPSQRR | 1631 | Q68DN1 | |
| GPRRHSGPRRTQAQL | 91 | Q7Z4H4 | |
| REPANGTNPSAELHR | 856 | Q96P47 | |
| RARPPRVLERSGFHN | 661 | Q6ZRH7 | |
| SIDRNIHRNLSPGIP | 151 | Q7L0X2 | |
| PQHNSSGASPRRVRH | 206 | Q9BRD0 | |
| EPSPADQLGNGHRRT | 776 | Q86XL3 | |
| HLRSNTPLQPRGQSA | 316 | O00421 | |
| PQRSCSAAGLHRPRS | 486 | P54646 | |
| QRGEQHRAQRPPSEA | 586 | Q8NEN0 | |
| QGRDSRAPLQSHRPH | 136 | Q155Q3 | |
| RASHAGQPRLRSSCP | 41 | Q49A92 | |
| PGRTASLNQRPRTHS | 226 | Q8IZP0 | |
| SLNLHRDPQRSNKPG | 386 | A6QL63 | |
| NPSVSPANQRRHLLG | 406 | P18850 | |
| HLRDRNSRQPSNLPG | 611 | O15484 | |
| GNSRPLQPLAHRALR | 286 | O75493 | |
| LQPLAHRALRGNRDP | 291 | O75493 | |
| APISRRRRHPDDAGQ | 2321 | Q9NYQ6 | |
| PRRRDGPEHATRLNG | 146 | Q92997 | |
| IRADHNTVLPGRPRQ | 1091 | Q9NSY1 | |
| ARGSQRVLPQAHCRP | 131 | Q9NZU7 | |
| RGPRPLDRERNSSHV | 1161 | Q9H251 | |
| GPNSPDHQQLTRAAR | 171 | Q8N4T4 | |
| RQERGLHGPLTLNSP | 1291 | Q06278 | |
| NIHNALRRRVVPPAS | 46 | P54107 | |
| PRRHAPLEQLVRQGS | 291 | Q9Y6R0 | |
| PASQSQVHLRPDRRG | 211 | Q9H0J4 | |
| DFRNPGPGRHRLITQ | 881 | Q96HW7 | |
| PSSPLDKQQRQHLRG | 36 | Q86XR2 | |
| PPNSDRNKSQRLEGH | 796 | Q9Y5F3 | |
| QRPPASSATLRRQRH | 901 | Q9NPG4 | |
| ASSPAQRRRGNDPLT | 11 | P49736 | |
| RTGSPRRIQLSQNHP | 1041 | Q08999 | |
| HLSAQATALARPRRP | 66 | Q8N9V6 | |
| HLPNPRDLSNTISRG | 71 | Q9NRD9 | |
| SHLSPGSIIQPQRRR | 51 | Q9Y618 | |
| AQSPPGTAVLRLRAH | 696 | Q96JQ0 | |
| LQGRRPRAQAPSASH | 341 | Q96DN6 | |
| LRQHRPLGRTQSAPL | 456 | P56524 | |
| QESAGSQRRLPPRHG | 6 | Q86VZ4 | |
| SPRRNGSGQSRHRLP | 11 | P0DP75 | |
| DAGRSSRHPPEQRRR | 1466 | Q96QZ7 | |
| GTNSARQSPALQHRP | 946 | Q5TCQ9 | |
| QDGRSRDGLSPQARH | 396 | Q14500 | |
| GPQSVRDDPRIQHCR | 1321 | Q86VF7 | |
| HLTQRPTLNRPVSRA | 56 | P55103 | |
| ASRLQEHSPEPRRAR | 51 | A8MQB3 | |
| KTHRPRSPRQNSIGN | 686 | Q99700 | |
| QRHESLRPAAGQSRP | 406 | Q9UKG1 | |
| PQAQQRRSHGSPRRR | 81 | Q08397 | |
| LGRQPRGRPHREAAQ | 306 | Q96KN9 | |
| QAVRRRHNAGSNPTP | 791 | Q96RV3 | |
| QAIRRRHNAGSNPTP | 586 | Q9H6A9 | |
| LSREHPPQSQIRGRA | 756 | Q9H5P4 | |
| RGAPPRRSSIRNAHS | 296 | P14598 | |
| NLNAPRTPGRHGLTT | 46 | Q96M96 | |
| PASVPNVGAIRRRHS | 466 | O15409 | |
| RHSRNPATRGLPSTA | 316 | P48730 | |
| LTAPRRAQRPHGGAE | 46 | Q8N819 | |
| ATGRPQHLPSTVRRD | 871 | O95644 | |
| RSGPRRQLNFDSPAD | 91 | Q5T7B8 | |
| SQVREADRHPGSPRR | 251 | Q5VZ66 | |
| TVRERRPSQPHTQSG | 206 | Q6ZTU2 | |
| VGANRASHRAAAPPR | 976 | P08151 | |
| EHSRIPRSQIQRARP | 36 | O15553 | |
| PLRRGLSHRSDPNAV | 41 | Q6PGN9 | |
| QSQLRSPLGPRHETA | 2216 | O15230 | |
| HAGPRGDPQRHSQSR | 1476 | Q08378 | |
| QLDPASGTRNFHPRR | 1301 | Q9C091 | |
| EAIARNPHRIPNNTR | 6 | Q8TCQ1 | |
| KRGAPPRRSSIRNVH | 296 | A6NI72 | |
| KRGAPPRRSSIRNAH | 271 | A8MVU1 | |
| LPAAGSSHLQQPRRL | 106 | P23677 | |
| SQQRRPRVCSGEGPH | 751 | Q9Y5I0 | |
| HNFQSRPPSGRRLSP | 286 | Q96GM1 | |
| LSRRGHAAPRATDQP | 1191 | Q86UR5 | |
| SRATPQCQRPHGSGR | 861 | O43182 | |
| KQEPHPGTSRQRQTR | 46 | Q99575 | |
| HTQIRDPRLRPYQSG | 331 | Q9H3Q3 | |
| LSGGSRQHEAPSNRP | 161 | P10398 | |
| KVPSPGQQRSRSLHR | 1831 | O95996 | |
| HSRTDNRPRNPREAK | 556 | Q06787 | |
| LNGTPRELRHQLGPS | 1001 | Q8NHM5 | |
| NLASQSRRENHKGPP | 2231 | Q4AC94 | |
| QVSPVRRAPSRRHGV | 421 | P15169 | |
| RRRSHQEPQRADSPL | 521 | P09603 | |
| APATLRAPQRHSRGE | 366 | I3L273 | |
| TQAGRPRPTSQGRSH | 1036 | Q4ZHG4 | |
| RSQRGHAASPARPSR | 1126 | Q4ZHG4 | |
| QRAQIQPRHRSASPA | 656 | Q8IX06 | |
| SNDPDRNHLTRAPRV | 111 | P35613 | |
| TVHSAPNRGLGRRPS | 901 | Q86UU0 | |
| RDSGASPGAQPQRHR | 131 | P0C7T7 | |
| NSRTPEAAPRGQRLE | 21 | Q7Z6J4 | |
| DPQRGRPQQRSHISR | 251 | Q9ULL0 | |
| RALRGPGPRSSLDQH | 666 | Q8IWT3 | |
| QALLRPRPGQATSHI | 281 | Q8TE02 | |
| SLNHEAPTPRSQLGR | 936 | Q9Y3R0 | |
| PLRGQRRTQDFPSDH | 116 | D6RIA3 | |
| TQPEPRHRAVCGRSR | 891 | Q12770 | |
| RQQPSGDRDACRLHP | 11 | Q9Y2W3 | |
| VRPRANGDVGPLSHR | 2111 | Q01668 | |
| HRAQRVRRPIPGSDQ | 151 | Q06587 | |
| HCRRSRLLNTPDGTP | 681 | Q8WYK1 | |
| PRNFSHNSLRGARPQ | 171 | Q14154 | |
| QGRREPPASGSHRVL | 231 | Q96A99 | |
| ARPRHPAEAPNNGAR | 441 | O14654 | |
| GSRPAQAVRARPRSN | 686 | Q8N4C8 | |
| HQSPSAERRGLNLAP | 726 | Q5VT03 | |
| RRQLRATGRPPSTEH | 131 | Q96S99 | |
| RHSSNTDNIPPERNR | 16 | Q96EX2 | |
| QSEPHGSPISRRNRE | 31 | Q5ST30 | |
| QDGRSRDGLSPQARH | 396 | B7U540 | |
| RLGQDDPTPSRINHN | 951 | Q9NRR4 | |
| RLAQNAARIPGIPRH | 591 | Q9UPN9 | |
| GLRRANSVQASRPAP | 266 | Q9Y2J0 | |
| GLNNDSPERRRRPGH | 901 | Q7Z6B7 | |
| ARSRSQKLPQRSHGP | 26 | Q7Z6J9 | |
| NRSRSHPRAPGGVNS | 111 | A6NKL6 | |
| SRRAQPPITQERGDA | 131 | Q9UPU3 | |
| QPRPGRLQHLQASLS | 166 | O94761 | |
| EQNSLHDRRDRGPPR | 151 | Q96GI7 | |
| TEQHSRRPIQRGAPS | 356 | Q9Y2N7 | |
| LARRVRSDPPSTGNH | 556 | Q5U5Q3 | |
| PRGARSHNPRNPAST | 1341 | Q13635 | |
| PLLSNELHRQRSPGV | 31 | Q8IZM9 | |
| NESRRGSLFVPHRPQ | 581 | Q15858 | |
| GSLFVPHRPQERRSS | 586 | Q15858 | |
| PHRPQERRSSNISQA | 591 | Q15858 | |
| ARQRRAPADEGHRPL | 76 | P0DJ93 | |
| SRAPRAHRDINVPRA | 211 | A6NL88 | |
| AFQVPRRPGHAARRQ | 346 | B8ZZ34 | |
| HGAAVSRTNRRGVPP | 1101 | Q9C0D5 | |
| QRPPRGSQSADTHGR | 931 | Q6ZUB1 | |
| PAAGLFHPGRRQSRQ | 21 | Q9BSE5 | |
| FHPGRRQSRQASDAP | 26 | Q9BSE5 | |
| RQRTSPPLGGHFRIQ | 781 | P08F94 | |
| RQVHLRGRPASQPTV | 281 | Q68BL8 | |
| DRAKIQHSRRPPTRG | 156 | Q53GL0 | |
| RPQDGPREHQTGSAR | 1481 | O15047 | |
| ASQPSAHISPRQRRA | 331 | Q7RTU9 | |
| RALRVAAAHPRQSPT | 6 | Q9UL12 | |
| LHRRRPRGQPASENA | 36 | Q8NCQ2 | |
| TPRDRRPQADTSLHG | 291 | Q96LP6 | |
| GSAKQQPRHSREVPR | 91 | Q8N7H1 | |
| GISLSSPRRNHETRP | 11 | Q8NAA6 | |
| SRPAHTRLALPGRQG | 56 | Q8N5U0 | |
| VPLPRHLSERSEQNR | 216 | Q9H1E5 | |
| PPSASGHERRQRPEA | 11 | Q5M7Z0 | |
| GTQLNPSRRPHGSTL | 661 | Q92738 | |
| SPGARSRHRQPVKNS | 211 | O00308 | |
| EHALLGRQPRTPERQ | 181 | O75467 | |
| GSSSHASRPQEPRNR | 351 | Q6ZNA4 | |
| SPRQAQATGAGPRHL | 211 | Q15772 | |
| AHQEAPVTSRPARAR | 2781 | Q15772 | |
| NPQALRPLGHRTGTL | 3111 | Q15772 | |
| ALSPRRLHQEAPSNS | 1171 | A0A1B0GUW6 | |
| PHAATRLSLQQPRAE | 571 | Q92766 | |
| PRQARRAEPSLHQVV | 1181 | Q9UPX0 | |
| KGRNRRTHAPEPRAE | 726 | Q13214 | |
| PPLRLARNGSHQVTL | 76 | P35590 | |
| ESNRRQNPALSPAHG | 876 | Q9P2F5 | |
| KHRSRPTSQPRGNIV | 36 | Q5JUX0 | |
| TDAQDPGLQRRPRHR | 121 | A8MWX3 | |
| PGHRSERAIRTQPKQ | 146 | O43609 | |
| HARARGPRAVLTRQP | 1021 | Q9NW08 | |
| AAQHRQEGPRKSPRQ | 1111 | Q9UGU0 | |
| VRRRSRDVPESPQHA | 296 | P13994 | |
| RLHRAATAGPPNARQ | 1011 | Q9UPT8 | |
| RPRNSHTNHRGPVDG | 11 | Q9P2E3 | |
| SPRDRGRISAHQGAQ | 856 | O95049 | |
| DGAISPNGHRPQLRA | 1071 | Q641Q2 | |
| RRFGRLQTARPPTAH | 71 | Q8TAG6 | |
| ASQPSAHISPRQRRA | 331 | A6NGW2 | |
| NQRGLRDPGPSTHDI | 551 | Q9H7P9 | |
| RLARNTRQSPHPREL | 141 | Q92508 | |
| HGNSVTSRPRPERNI | 406 | Q9C0G0 | |
| SPLVRERGPQRVAAH | 111 | P50591 | |
| RHPQPQGLEVTGDRR | 141 | Q6ZMP0 | |
| GTPSHSRRQPRVVSQ | 166 | Q6PJE2 | |
| RPPHLRRATVFANGS | 271 | Q13308 | |
| TRFQPGNLRPNRHLA | 61 | Q8IYM9 | |
| RPPASRNADSGVHLN | 216 | Q6PJT7 | |
| HQRLHSREGPSRCPQ | 501 | Q86UD4 | |
| ERDQRPSSPIRHQGR | 636 | Q5T200 | |
| SDSLQRQTPRHAAPG | 2506 | O75962 | |
| GPESGLSRNNPHTRE | 31 | Q3MJ62 | |
| HLGRRARLPAAQPSA | 6 | Q86TJ5 | |
| NSPPRARAGGRHVLV | 716 | Q5VV43 | |
| LPRGPDSQRQDGRVH | 1586 | Q9NR99 | |
| ERIPNTAFRGLRQHP | 101 | Q8N9F0 |